Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ3R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,259
Award facts
- Contract value 100% obligated
- $7,258.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,258.92 by the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. Performance will be completed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 14, 2026. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide.
The DLA Medical Supply Chain relies on pharmaceutical distributors like Amerisourcebergen to ensure the availability of critical medications across therapeutic domains to support military treatment facilities and veteran healthcare programs globally. Repatha, a specialty cardiovascular medication used for cholesterol management, represents the type of brand-name pharmaceutical product that DLA procures to meet the medical needs of service members and beneficiaries. The delivery order structure under the larger indefinite delivery contract allows for flexible, on-demand procurement of essential medications while maintaining competitive pricing through firm fixed-price mechanisms.
Quick answers
Who was awarded contract SPE2DR26FCZ3R?
SPE2DR26FCZ3R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FCZ3R worth?
The government has obligated $7,259 on SPE2DR26FCZ3R.
Is contract SPE2DR26FCZ3R an order under another contract?
Yes. SPE2DR26FCZ3R is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ3R competed?
The extent of competition for SPE2DR26FCZ3R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award